Free Trial

Danaher (DHR) Stock Price, News & Analysis

Danaher logo
$190.43 +1.89 (+1.00%)
Closing price 03:59 PM Eastern
Extended Trading
$190.67 +0.24 (+0.13%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Danaher Stock (NYSE:DHR)

Advanced

Key Stats

Today's Range
$187.76
$192.07
50-Day Range
$188.23
$212.24
52-Week Range
$171.00
$279.90
Volume
4.82 million shs
Average Volume
3.20 million shs
Market Capitalization
$136.36 billion
P/E Ratio
40.52
Dividend Yield
0.67%
Price Target
$246.35
Consensus Rating
Moderate Buy

Company Overview

Danaher Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

DHR MarketRank™: 

Danaher scored higher than 100% of companies evaluated by MarketBeat, and ranked 9th out of 960 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Danaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.85, and is based on 17 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Danaher has a consensus price target of $246.35, representing about 29.4% upside from its current price of $190.43.

  • Amount of Analyst Coverage

    Danaher has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Danaher's stock forecast and price target.
  • Earnings Growth

    Earnings for Danaher are expected to grow by 12.32% in the coming year, from $7.63 to $8.57 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Danaher is 40.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 268.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Danaher is 40.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 57.12.

  • Price to Earnings Growth Ratio

    Danaher has a PEG Ratio of 2.63. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Danaher has a P/B Ratio of 2.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Danaher's valuation and earnings.
  • Percentage of Shares Shorted

    1.46% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently increased by 0.84%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Danaher has a dividend yield of 0.68%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Danaher has only been increasing its dividend for 2 years.

  • Dividend Coverage

    The dividend payout ratio of Danaher is 27.23%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Danaher will have a dividend payout ratio of 14.94% next year. This indicates that Danaher will be able to sustain or increase its dividend.

  • Read more about Danaher's dividend.
  • Percentage of Shares Shorted

    1.46% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently increased by 0.84%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Danaher has a news sentiment score of 1.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 57 news articles for Danaher this week, compared to 48 articles on an average week.
  • Search Interest

    37 people have searched for DHR on MarketBeat in the last 30 days. This is an increase of 9% compared to the previous 30 days.
  • MarketBeat Follows

    18 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is an increase of 350% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $586,325.00 in company stock.

  • Percentage Held by Insiders

    11.20% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    79.05% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Danaher's insider trading history.
Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DHR Stock News Headlines

Danaher (NYSE:DHR) Director Teri List Sells 2,778 Shares
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

DHR Stock Analysis - Frequently Asked Questions

Danaher's stock was trading at $229.55 at the beginning of the year. Since then, DHR stock has decreased by 17.0% and is now trading at $190.43.

Danaher Corporation (NYSE:DHR) released its quarterly earnings results on Tuesday, July, 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. The company's quarterly revenue was up 3.4% on a year-over-year basis.
Read the conference call transcript
.

Danaher subsidiaries include Aldevron, Precision NanoSystems, Aquatic Informatics, Cytiva, GE Biopharma, Integrated DNA Technologies, IDBS Group, and more.

Top institutional shareholders of Danaher include Vanguard Group Inc. (8.49%), State Street Corp (3.81%), Geode Capital Management LLC (1.92%) and Norges Bank (1.40%). Insiders that own company stock include Steven M Rales, Alan G Spoon, Rainer Blair, Joakim Weidemanis, Linda Filler, Daniel Raskas, Matthew Mcgrew, Teri List, Brian W Ellis, Christopher Paul Riley, Walter G Lohr, Raymond C Stevens, Jennifer Honeycutt, Jose-Carlos Gutierrez-Ramos and Georgeann Couchara.
View institutional ownership trends
.

Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Danaher investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), UnitedHealth Group (UNH), BlackRock (BLK), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Record date for 7/25 Dividend
6/27/2025
Last Earnings
7/22/2025
Dividend Payable
7/25/2025
Today
9/16/2025
Record date for 10/31 Dividend
9/26/2025
Ex-Dividend for 10/31 Dividend
9/26/2025
Next Earnings (Estimated)
10/28/2025
Dividend Payable
10/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Industrial Conglomerates
Current Symbol
NYSE:DHR
CIK
313616
Employees
63,000
Year Founded
1984

Price Target and Rating

High Price Target
$315.00
Low Price Target
$205.00
Potential Upside/Downside
+29.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.85
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.70
Trailing P/E Ratio
40.53
Forward P/E Ratio
24.93
P/E Growth
2.65
Net Income
$3.90 billion
Net Margins
14.21%
Pretax Margin
16.97%
Return on Equity
10.70%
Return on Assets
6.85%

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
1.62
Quick Ratio
1.22

Sales & Book Value

Annual Sales
$23.88 billion
Price / Sales
5.71
Cash Flow
$10.93 per share
Price / Cash Flow
17.40
Book Value
$68.60 per share
Price / Book
2.77

Miscellaneous

Outstanding Shares
716,050,000
Free Float
635,854,000
Market Cap
$136.23 billion
Optionable
Optionable
Beta
0.75

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:DHR) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners